Diabetes Technology Society
Nonprofit profile at a glance
- EIN
- 300012730
- IRS 990 coverage
- 2011–2025
- Forms available
- Form 990 2025
- Location
- Burlingame, CA, USA
- Phone
- 6504919109
- Rating
- 69
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Specifically Named Diseases
Reported finances
- Revenue
- $1,029,388
- Expenses
- $1,615,150
- Assets
- $1,420,913
- Liabilities
- $20,362
Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- DR DAVID KLONOFF MD (PRESIDENT)
Highest reported compensation
- DR DAVID KLONOFF MD (PRESIDENT): $306,747 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To facilitate research into the treatment, monitoring, diagnosis and prevention of diabetes.
What it reported doing in 2025
To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the diabetes technology field, maintaining a spanish/english dual-language informational website and publishing 204 technical articles and 13 research articles about diabetes and diabetes technology. Conferences held in 2025, the number of attendees and other projects are as follows:1.tools to distinguish t1d & t2d in adults (tools project)meeting #1: 2/4/2025, 14 attendeesmeeting #2: 2/5/2025, 14 attendeesmeeting #3: 5/29/2025: 29 attendeesmeeting #4: 8/13/2025, 14 attendees2. Integration of connected diabetes device data into the electronic health record #2 (icode-2)september 18, 2025no. Of attendees: 403. The role of the glycemia risk index diabetes technology meeting (gri meeting)october 27, 2025no. Of attendees: 484. Diabetes technology meeting (in-person) (dtm 2025)october 28-30, 2025no. Of attendees: 5005. The use of cgm to diagnose stage 2 t1d consensus panel (in-person presentation at the 2025 dtm)october 30, 2025 no. Of attendees: 500ongoing projects:1. Diabetes research hub (drh) - ongoing projectthe drh is a comprehensive data ecosystem designed to accelerate breakthroughs in diabetes research. We empower researchers by unlocking the potential of data trapped in proprietary medical devices and health systems. By creating a secure and user-friendly platform for data collection, analysis, and collaboration, the drh fuels next-generation research using ai and ml to develop personalized and effective solutions for diabetes.2. The dcb open innovation challengein collaboration with diabetes center berneongoing - launched on 4/1/2024 & featured at the dtm 2025 on 10/30/20253. Diabetes technology report(dts podcast)dts launched an ongoing podcast with leaders in the diabetes technology field.4. Saluddiabetes.orgdts launched a spanish/english dual-language website that summarizes recent publications in diabetes and health for the layperson.5. Optimizing lifestyle interventions for reversing insulin resistance - ongoing projectto analyze medical literature for interventions that improve insulin sensitivity (either by an effect on the liver, muscles, or production of insulin or natural glp-1ra hormone) that could become part of a behavioral tool to be used for people with prediabetes or who are at risk of diabetes to decrease their risk of developing type 2 diabetes.6. Jdst (journal of diabetes science and technology)published 204 technical articles about diabetes and diabetes technology after receiving 628 articles to review.7. Publication of 13 research articles by dts staff listed below:-evaluating the clinical utility of the glycemia risk index.j diabetes sci technol. 2025 oct 14:19322968251382604. Doi: 10.1177/19322968251382604. Online ahead of print. Pmid: 41216978 free pmc article.-machine learning to diagnose complications of diabetes. J diabetes sci technol. 2025 nov;19(6):1650-1670. Doi: 10.1177/19322968251365245. Epub 2025 sep 11. Pmid: 40932163 free pmc article. Review.-continuous glucose monitoring data analysis 2.0: functional data pattern recognition and artificial intelligence applications. J diabetes sci technol. 2025 nov;19(6):1515-1527. Doi: 10.1177/19322968251353228. Epub 2025 aug 14. Pmid: 40814224 free pmc article.-glucagon-like peptide-1 receptor agonists and peri-procedural aspiration risk. J endocr soc. 2025 jul 10;9(9): bvaf088. Doi: 10.1210/jendso/bvaf088. Ecollection 2025 sep. Pmid: 40893948 free pmc article. Review.-the need to transition from paper to electronic instructions for use for diabetes devices. Npj digit med. 2025 jun 13;8(1):356. Doi: 10.1038/s41746-025-01720-0. Pmid: 40514391 free pmc article.-diabetes devices: a growing environmental burden. Diabetes res clin pract. 2025 aug;226:112307. Doi: 10.1016/j.diabres.2025.112307. Epub 2025 jun
Operating model
- Revenue model
- Earned-program. 77% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Some filing-based governance responses are negative or unanswered and expenses are high relative to revenue.
Rating breakdown
- Financial Efficiency: 85
- Transparency & Controls: 70
- Accountability: 60
- Sustainability: 21
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 86.7%; rating input score 87
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 83.3%; rating input score 83; 1st percentile among comparable filings
- Pay-setting controls: 3 of 6 controls in place; rating input score 50
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Pass
- Written employment contract: Missing
- Compensation survey or study: Pass
- Board or committee approval: Pass
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 75%; rating input score 75; 19th percentile among comparable filings
- Governance controls: 3 of 8 controls in place; rating input score 38
- Conflict-of-interest policy: Fail
- Whistleblower policy: Fail
- Document-retention policy: Fail
- CEO compensation review process: Pass
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: -56.9%; rating input score 2; 2nd percentile among comparable filings
- Total-asset coverage ratio: 0.88; rating input score 39; 39th percentile among comparable filings
- Liabilities to assets ratio: 0.01; rating input score 57; 57th percentile among comparable filings
- Officer compensation ratio: 19%; rating input score 18; 18th percentile among comparable filings
Growth
- Program expense growth: -2.2% per year; rating input score 0; 10th percentile among comparable filings
- Revenue growth: -2.2% per year; rating input score 0; 7th percentile among comparable filings
- Asset growth: 3.4% per year; rating input score 100; 28th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 86.7% of spending went to programs
- Governance: 3 of 4 board members independent · 3 of 8 filing controls reported
- Programs: 1 filed program accomplishment · $1.4M in reported program spending
- Leadership: top reported pay $307K · 4 people listed · 3 of 6 pay-setting controls reported
- Highest-paid contractors: 1 contractor listed · $115K reported
- Consistency: 28 of 29 current checks pass · 1 finding to review
- Schedules: 5 filed schedules · includes major donors and executive pay
- Filing history: 15 filing years from 2011 to 2025
- Contacts: How to reach this organization
- Money network: 1 filed money-flow record
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
- Staff and benefit plans: Retirement and health plans the organization files with the Department of Labor, and the people in them.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Accountability: Governance controls: 4 of 7 not reported.
- High — Sustainability: Operating margin scored 2/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- Moderate — Sustainability: Total-asset coverage ratio scored 39/100.
- Review — Transparency & Controls: Foreign grants require schedule f did not reconcile in the filed values.
- High — Sustainability: Officer compensation ratio scored 18/100.
- Review — Sustainability: Liabilities to assets ratio scored 57/100.